The fund owned 310,337 shares of the biopharmaceutical company’s stock after selling 42,786 shares during the period. Truist Financial Corp’s holdings in Gilead Sciences were worth $34,447,000 as of its most recent SEC filing. J. Safra Sarasin Holding AG lifted its holdings in shares of Gilead Sciences by 22.9% during the 3rd quarter. Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Gilead Sciences, Inc. (NASDAQ:GILD – Free Report). Receive News & Ratings for Gilead Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gilead Sciences and related companies with MarketBeat.com's FREE daily email newsletter.